Servier Implements Veeva OpenData Worldwide to Enhance AI Capabilities

In a groundbreaking move, Servier, a prominent French pharmaceutical company, has taken a significant step towards redefining its operations by adopting Veeva OpenData across more than 80 countries. This strategic initiative aims to standardize and harmonize customer reference data, creating a robust foundation for artificial intelligence (AI) utilization in its global operations.

Traditionally, pharmaceutical companies have struggled with fragmented data systems, preventing them from making informed decisions efficiently. By unifying its data through Veeva OpenData, Servier is not merely enhancing its current processes but is setting the stage for a comprehensive AI-ready infrastructure. Liam Hanrahan, the Director of World Operations Excellence at Servier, emphasizes the importance of this transition, stating, "By centralizing our customer reference data through Veeva OpenData, we are building the global, AI-ready data foundation that will redefine how we work."

The adoption of Veeva OpenData is integrated with Veeva Link Key People, allowing Servier's various affiliates to access high-quality insights tailored to reach healthcare professionals (HCPs) across diverse markets. This initiative promises to streamline operations and drive both efficiency and effectiveness, particularly in deploying AI technologies. Hanrahan points out, "A globally unified semantic layer and Veeva Link connectivity give our affiliates the insights they need to reach the right HCPs in each market."

Kilian Weiss, President of Link and OpenData at Veeva, underscores the extensive challenges faced by the industry regarding AI implementation. He states, "The industry fails to scale 89% of AI initiatives due to data challenges." By taking a proactive approach through standardization, Servier not only leads in addressing these common hurdles but also amplifies its potential for effective AI-driven commercial execution.

The Importance of Data Standardization

In today’s fast-paced pharmaceutical landscape, the speed and quality of data can significantly impact a company's ability to innovate and maintain a competitive edge. OpenData’s capability to unify customer reference data globally replaces fragmented data silos. This consistent approach is crucial for advancing analytics and AI capabilities, which are increasingly becoming vital for strategic decision-making.

As part of the Veeva Data Cloud, Veeva OpenData integrates seamlessly with other vital tools such as Veeva Link and Veeva Compass, creating a cohesive system that empowers Servier’s global commercial and medical teams with connected data. This interconnectedness enables faster insights and quicker action, key components needed in the highly regulated and competitive pharmaceutical market.

Looking Ahead

The transition to an AI-ready platform through Veeva OpenData marks a pivotal moment for Servier. It showcases the company's commitment to innovation and operational excellence, ensuring that it not only keeps pace with industry advancements but potentially leads the charge in leveraging AI within pharmaceutical operations. The implications of such a move could set a new standard for how data is managed and utilized across the industry, fostering a more integrated, responsive framework.

Future implications of this shift could see a rise in more personalized medicine, quicker responses to market changes, and enhanced engagement with healthcare professionals. As Servier continues on this journey, it serves as a model for other organizations seeking to harness the full potential of AI through innovative data management solutions.

For further information, visit Veeva Systems.